118 related articles for article (PubMed ID: 38408033)
1. Compromise in Docking Power of Liganded Crystal Structures of M
Zajaček D; Dunárová A; Bucinsky L; Štekláč M
J Chem Inf Model; 2024 Mar; 64(5):1628-1643. PubMed ID: 38408033
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro.
Zev S; Raz K; Schwartz R; Tarabeh R; Gupta PK; Major DT
J Chem Inf Model; 2021 Jun; 61(6):2957-2966. PubMed ID: 34047191
[TBL] [Abstract][Full Text] [Related]
3. Pea eggplant (
Govender N; Zulkifli NS; Badrul Hisham NF; Ab Ghani NS; Mohamed-Hussein ZA
PeerJ; 2022; 10():e14168. PubMed ID: 36518265
[TBL] [Abstract][Full Text] [Related]
4. Benchmarked molecular docking integrated molecular dynamics stability analysis for prediction of SARS-CoV-2 papain-like protease inhibition by olive secoiridoids.
Thangavel N; Albratty M
J King Saud Univ Sci; 2023 Jan; 35(1):102402. PubMed ID: 36338939
[TBL] [Abstract][Full Text] [Related]
5. Combining fragment docking with graph theory to improve ligand docking for homology model structures.
Sarfaraz S; Muneer I; Liu H
J Comput Aided Mol Des; 2020 Dec; 34(12):1237-1259. PubMed ID: 33034007
[TBL] [Abstract][Full Text] [Related]
6. The Performance of Several Docking Programs at Reproducing Protein-Macrolide-Like Crystal Structures.
Castro-Alvarez A; Costa AM; Vilarrasa J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28106755
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the substrate-binding site of main protease for the structure-based COVID-19 drug discovery.
Firouzi R; Ashouri M; Karimi-Jafari MH
Proteins; 2022 May; 90(5):1090-1101. PubMed ID: 35119780
[TBL] [Abstract][Full Text] [Related]
8. Comparative Evaluation of Covalent Docking Tools.
Scarpino A; Ferenczy GG; Keserű GM
J Chem Inf Model; 2018 Jul; 58(7):1441-1458. PubMed ID: 29890081
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power.
Wang Z; Sun H; Yao X; Li D; Xu L; Li Y; Tian S; Hou T
Phys Chem Chem Phys; 2016 May; 18(18):12964-75. PubMed ID: 27108770
[TBL] [Abstract][Full Text] [Related]
10. Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 M
Soulère L; Barbier T; Queneau Y
Comput Biol Chem; 2021 Jun; 92():107463. PubMed ID: 33677227
[TBL] [Abstract][Full Text] [Related]
11. Comparative Assessment of Pose Prediction Accuracy in RNA-Ligand Docking.
Agarwal R; T RR; Smith JC
J Chem Inf Model; 2023 Dec; 63(23):7444-7452. PubMed ID: 37972310
[TBL] [Abstract][Full Text] [Related]
12. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
Hajbabaie R; Harper MT; Rahman T
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
[TBL] [Abstract][Full Text] [Related]
13. De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations.
Arshia AH; Shadravan S; Solhjoo A; Sakhteman A; Sami A
Comput Biol Med; 2021 Dec; 139():104967. PubMed ID: 34739968
[TBL] [Abstract][Full Text] [Related]
14. Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19.
Rehman MT; AlAjmi MF; Hussain A
Curr Pharm Des; 2021; 27(33):3577-3589. PubMed ID: 33200697
[TBL] [Abstract][Full Text] [Related]
15. Natural inhibitors of SARS-CoV-2 main protease: structure based pharmacophore modeling, molecular docking and molecular dynamic simulation studies.
Halimi M; Bararpour P
J Mol Model; 2022 Aug; 28(9):279. PubMed ID: 36031629
[TBL] [Abstract][Full Text] [Related]
16. A fully differentiable ligand pose optimization framework guided by deep learning and a traditional scoring function.
Wang Z; Zheng L; Wang S; Lin M; Wang Z; Kong AW; Mu Y; Wei Y; Li W
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36502369
[TBL] [Abstract][Full Text] [Related]
17. dockECR: Open consensus docking and ranking protocol for virtual screening of small molecules.
Ochoa R; Palacio-Rodriguez K; Clemente CM; Adler NS
J Mol Graph Model; 2021 Dec; 109():108023. PubMed ID: 34555725
[TBL] [Abstract][Full Text] [Related]
18. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.
Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF
Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249
[TBL] [Abstract][Full Text] [Related]
19. Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M
Bassani D; Pavan M; Bolcato G; Sturlese M; Moro S
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215293
[TBL] [Abstract][Full Text] [Related]
20. Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition.
Macip G; Garcia-Segura P; Mestres-Truyol J; Saldivar-Espinoza B; Ojeda-Montes MJ; Gimeno A; Cereto-Massagué A; Garcia-Vallvé S; Pujadas G
Med Res Rev; 2022 Mar; 42(2):744-769. PubMed ID: 34697818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
